Welcome to LookChem.com Sign In|Join Free
  • or
2,9-Dichloroacridine is a fluorescent yellow dye and an acridine compound with the molecular formula C13H8Cl2N2. It is characterized by its high melting point and solubility in organic solvents, while being insoluble in water. This versatile chemical is known for its antimicrobial and antineoplastic activities, making it a valuable target for research in the development of new drugs and therapies.

1019-14-3

Post Buying Request

1019-14-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1019-14-3 Usage

Uses

Used in Dye and Pigment Manufacturing:
2,9-Dichloroacridine is used as a dye in the manufacturing of various industrial products due to its fluorescent yellow color.
Used in Fluorescence-based Laboratory Assays:
2,9-DICHLOROACRIDINE serves as a fluorescent marker in laboratory assays, aiding in the visualization and analysis of biological samples.
Used as an Intermediate in Chemical Production:
2,9-Dichloroacridine is utilized as an intermediate in the production of pharmaceuticals, agrochemicals, and other specialty chemicals, contributing to the synthesis of a wide range of products.
Used in Antimicrobial Applications:
Leveraging its antimicrobial properties, 2,9-Dichloroacridine is a candidate for research and development in the creation of new antimicrobial agents to combat infections.
Used in Antineoplastic Drug Development:
The antineoplastic activity of 2,9-Dichloroacridine makes it a promising candidate for research in the development of new drugs and therapies for the treatment of cancer.

Check Digit Verification of cas no

The CAS Registry Mumber 1019-14-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,0,1 and 9 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1019-14:
(6*1)+(5*0)+(4*1)+(3*9)+(2*1)+(1*4)=43
43 % 10 = 3
So 1019-14-3 is a valid CAS Registry Number.

1019-14-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,9-DICHLOROACRIDINE

1.2 Other means of identification

Product number -
Other names 2,5-FURANDIONE,POLYMER WITH 1,2-ETHANEDIOL AND 3

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1019-14-3 SDS

1019-14-3Relevant academic research and scientific papers

Synthesis and biological evaluation of benzimidazole acridine derivatives as potential DNA-binding and apoptosis-inducing agents

Gao, Chunmei,Li, Bin,Zhang, Bin,Sun, Qinsheng,Li, Lulu,Li, Xi,Chen, Changjun,Tan, Chunyan,Liu, Hongxia,Jiang, Yuyang

, p. 1800 - 1807 (2015)

The discovery of new effective DNA-targeted antitumor agent is needed because of their clinical significance. As acridines can intercalate into DNA and benzimidazoles have the ability to bind in the DNA minor groove, a series of novel benzimidazole acridine derivatives were designed and synthesized to be new DNA-targeted compounds. MTT assay indicated that most of the synthesized compounds displayed good antiproliferative activity, among which compound 8l demonstrated the highest activity against both K562 and HepG-2 cells. Further experiments showed that 8l displayed good DNA-binding capability and inhibited topoisomerase I activity. Moreover, compound 8l could induce apoptosis in K562 cell lines through mitochondrial pathway. These data suggested that compound 8l might be potential as new DNA-binding and apoptosis-inducing antitumor agents.

Design and synthesis of some acridine-piperazine hybrids for the improvement of cognitive dysfunction

Sharma, Anuradha,Piplani, Poonam

, p. 926 - 935 (2017/10/06)

A novel series of hybrid molecules (5a–5m) was designed, synthesized and evaluated as multifunctional cholinesterase (ChE) inhibitors against cognitive dysfunction. Heterocyclic moieties acridine and piperazine were conjugated with suitable linkers in a single scaffold, and the structures of the target compounds were confirmed by IR, 1H NMR, 13C NMR, and LC-MS analysis. The pharmacological activity of synthesized compounds was evaluated using behavioral models of amnesia viz. step-down passive avoidance and elevated plus maze at a dose 0.5?mg/kg as compared to standard rivastigmine. In vitro acetylcholinesterase (AChE) inhibition studies using brain homogenate of mice as the enzyme source revealed that most of the compounds exhibited a significant ability to inhibit the enzyme cholinesterase with compound 5c being the most potent (IC50 0.33?μm). Biochemical estimation of oxidative stress markers viz. plasma nitrite, thiobarbituric acid reactive substances, catalase, superoxide dismutase, and glutathione has been carried out using the respective assays to see the effect of the synthesized compounds on the scopolamine-induced oxidative damage. The molecular docking studies indicated the binding mode of the compounds to the catalytic site, peripheral site, and mid-gorge of AChE simultaneously. The calculated absorption, distribution, metabolism and excretion properties ensured the drug-likeness of the target compounds. The synthesized compounds were found to be potential cognitive enhancers, which were able to interfere with the scopolamine-induced oxidative stress also.

Development of acridine derivatives as selective Mycobacterium tuberculosis DNA gyrase inhibitors

Medapi, Brahmam,Meda, Nikhila,Kulkarni, Pushkar,Yogeeswari, Perumal,Sriram, Dharmarajan

, p. 877 - 885 (2016/05/24)

In this study we have designed p-phenylene diamine linked acridine derivative from our earlier reported quinoline-aminopiperidine hybrid MTB DNA gyrase inhibitors with aiming more potency and less cardiotoxicity. We synthesized thirty six compounds using four step synthesis from 2-chloro benzoic acid. Among them compound 4-chloro-N-(4-((2-methylacridin-9-yl)amino)phenyl)benzenesulphonamide (6) was found to be more potent with MTB DNA gyrase super coiling IC50of 5.21 ± 0.51 μM; MTB MIC of 6.59 μM and no zHERG cardiotoxicity at 30 μM and 11.78% inhibition at 50 μM against mouse macrophage cell line RAW 264.7.

The Effects of Substituents Introduced into 9-Aminoacridine on Frameshift Mutagenicity and DNA Binding Affinity

Tomosaka, Hideyuki,Omata, Saburo,Hasegawa, Eietsu,Anzai, Kentaro

, p. 1121 - 1125 (2007/10/03)

Some derivatives of 9-aminoacridine (1) were synthesized, and their frameshift mutagenicity and DNA binding affinity were studied. The introduction of a methyl group into the acridine ring of 1 reduced the mutagenic activity and the intercalative DNA bind

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1019-14-3